Cochlear Ltd
COH: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| A$749.00 | Vspb | Hgjtqlzqp |
Elevated Growth Unlikely to Stay; Cochlear Shares Remain Expensive
Business Strategy and Outlook
Cochlear is the market leader in cochlear implants with consistent share of roughly 60% across developed markets. Cochlear implants became the standard of care many years ago for children in developed markets with profound hearing loss or deafness. With this market segment largely penetrated, the company is looking elsewhere for growth with developed-markets adults the next primary focus and emerging-markets children after that.